BEHIND THE NEWS: Guidant sale not so sweet for holders of buyer’s stock
With almost every passing day, Boston Scientific Inc.’s $27 billion purchase of India n a p o l i s – b a s e d Guidant Corp. looks like a bigger fiasco-for the buyer, that is. Whether it was bad for the sellers-Guidant shareholders-is a trickier question. They received a stew of stock and cash in the deal and fared splendidly if they immediately sold their shares. But if they didn’t, Massachusettsbased Boston Scientific’s $80-a-share offer has lost its…